Case Reports of Adipose-derived Stem Cell Therapy for Nasal Skin Necrosis after Filler Injection

 

 Permissions and Reprints

With the gradual increase of cases using fillers, cases of patients treated by non-medical professionals or inexperienced physicians resulting in complications are also increasing. We herein report 2 patients who experienced acute complications after receiving filler injections and were successfully treated with adipose-derived stem cell (ADSCs) therapy. Case 1 was a 23-year-old female patient who received a filler (Restylane) injection in her forehead, glabella, and nose by a non-medical professional. The day after her injection, inflammation was observed with a 3×3 cm skin necrosis. Case 2 was a 30-year-old woman who received a filler injection of hyaluronic acid gel (Juvederm) on her nasal dorsum and tip at a private clinic. She developed erythema and swelling in the filler-injected area A solution containing ADSCs harvested from each patient's abdominal subcutaneous tissue was injected into the lesion at the subcutaneous and dermis levels. The wounds healed without additional treatment. With continuous follow-up, both patients experienced only fine linear scars 6 months postoperatively. By using adipose-derived stem cells, we successfully treated the acute complications of skin necrosis after the filler injection, resulting in much less scarring, and more satisfactory results were achieved not only in wound healing, but also in esthetics.

Publication History

Received: 10 June 2011

Accepted: 13 October 2011

Article published online:
01 May 2022

© 2012. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Utsunomiya T, Shimada M, Imura S. et al. Human adiposederived stem cells: potential clinical applications in surgery. Surg Today 2011; 41: 18-23
  CrossrefPubMedGoogle Scholar
• 2 Klein AW, Elson ML. The history of substances for soft tissue augmentation. Dermatol Surg 2000; 26: 1096-1105
  CrossrefPubMedGoogle Scholar
• 3 Weinberg MJ, Solish N. Complications of hyaluronic acid fillers. Facial Plast Surg 2009; 25: 324-328
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Grunebaum LD, Bogdan Allemann I, Dayan S. et al. The risk of alar necrosis associated with dermal filler injection. Dermatol Surg 2009; 35 (Suppl. 02) 1635-1640
  CrossrefPubMedGoogle Scholar
• 5 Brody HJ. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg 2005; 31: 893-897
  CrossrefPubMedGoogle Scholar
• 6 Zuk PA, Zhu M, Ashjian P. et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295
  CrossrefPubMedGoogle Scholar
• 7 Hong SJ, Traktuev DO, March KL. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr Opin Organ Transplant 2010; 15: 86-91
  CrossrefPubMedGoogle Scholar
• 8 Kim WS, Park BS, Sung JH. et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007; 48: 15-24
  CrossrefPubMedGoogle Scholar